The Effect of Chemotherapy Regimens in Male Germ Cell Tumors on the Development of Primary Hypogonadism
November 2024
in “
Scientific Reports
”
Studysummary In this study, researchers at a tertiary cancer center observed that many male germ cell tumor survivors experienced degrees of hypogonadism and erectile dysfunction, highlighting the clinical need to monitor endocrine health in cancer survivors.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on nature.com →